{"entity":{"type":"insider","cik":"0001704255","url":"/insider/0001704255","json_url":"/insider/0001704255.json","name":"Engelhart James","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":19,"n_filings":9,"first":"2017-05-11","last":"2021-12-10","span_basis":"filed_date"},"name_variants":[{"name":"Engelhart James","source":"filing","n_filings":9,"first_seen":"2017-05-11","last_seen":"2021-12-10"}],"transactions":[{"id":5325869,"accession":"0001562180-21-007628","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-007628","line_url":"/filing/0001562180-21-007628#line-4","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23487.0,"shares_display":"23,487","price_per_share":102.702,"price_display":"102.70","price_state":"stated","total_value":2412161.874,"total_display":"2,412,161.87","shares_owned_after":12578.0,"shares_owned_after_display":"12,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-10","scope":"insider"},{"id":5325867,"accession":"0001562180-21-007628","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-21-007628","line_url":"/filing/0001562180-21-007628#line-3","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10131.0,"shares_display":"10,131","price_per_share":102.0104,"price_display":"102.01","price_state":"stated","total_value":1033467.3624,"total_display":"1,033,467.36","shares_owned_after":36065.0,"shares_owned_after_display":"36,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-10","scope":"insider"},{"id":5325863,"accession":"0001562180-21-007628","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-007628","line_url":"/filing/0001562180-21-007628#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1382.0,"shares_display":"1,382","price_per_share":103.8469,"price_display":"103.85","price_state":"stated","total_value":143516.4158,"total_display":"143,516.42","shares_owned_after":11196.0,"shares_owned_after_display":"11,196","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-10","filed_date":"2021-12-10","scope":"insider"},{"id":2270132,"accession":"0001562180-20-004453","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001562180-20-004453","line_url":"/filing/0001562180-20-004453#line-11","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6501.0,"shares_display":"6,501","price_per_share":64.3067,"price_display":"64.31","price_state":"stated","total_value":418057.8567,"total_display":"418,057.86","shares_owned_after":6974.0,"shares_owned_after_display":"6,974","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-12","scope":"insider"},{"id":2270129,"accession":"0001562180-20-004453","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001562180-20-004453","line_url":"/filing/0001562180-20-004453#line-10","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5972.0,"shares_display":"5,972","price_per_share":62.0726,"price_display":"62.07","price_state":"stated","total_value":370697.5672,"total_display":"370,697.57","shares_owned_after":18322.0,"shares_owned_after_display":"18,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-12","scope":"insider"},{"id":2270119,"accession":"0001562180-20-004453","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001562180-20-004453","line_url":"/filing/0001562180-20-004453#line-9","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4847.0,"shares_display":"4,847","price_per_share":63.1909,"price_display":"63.19","price_state":"stated","total_value":306286.2923,"total_display":"306,286.29","shares_owned_after":13475.0,"shares_owned_after_display":"13,475","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-12","scope":"insider"},{"id":2270116,"accession":"0001562180-20-004453","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001562180-20-004453","line_url":"/filing/0001562180-20-004453#line-8","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2452.0,"shares_display":"2,452","price_per_share":64.8513,"price_display":"64.85","price_state":"stated","total_value":159015.3876,"total_display":"159,015.39","shares_owned_after":4522.0,"shares_owned_after_display":"4,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-12","scope":"insider"},{"id":2270111,"accession":"0001562180-20-004453","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-20-004453","line_url":"/filing/0001562180-20-004453#line-6","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28821.0,"shares_display":"28,821","price_per_share":66.6575,"price_display":"66.66","price_state":"stated","total_value":1921135.8075,"total_display":"1,921,135.81","shares_owned_after":29654.0,"shares_owned_after_display":"29,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-12","scope":"insider"},{"id":2270108,"accession":"0001562180-20-004453","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-20-004453","line_url":"/filing/0001562180-20-004453#line-5","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24832.0,"shares_display":"24,832","price_per_share":67.5334,"price_display":"67.53","price_state":"stated","total_value":1676989.3888,"total_display":"1,676,989.39","shares_owned_after":4822.0,"shares_owned_after_display":"4,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-12","scope":"insider"},{"id":2270105,"accession":"0001562180-20-004453","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-004453","line_url":"/filing/0001562180-20-004453#line-4","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":68.0667,"price_display":"68.07","price_state":"stated","total_value":20420.01,"total_display":"20,420.01","shares_owned_after":4522.0,"shares_owned_after_display":"4,522","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-10","filed_date":"2020-06-12","scope":"insider"},{"id":7950247,"accession":"0001209191-19-039412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-039412","line_url":"/filing/0001209191-19-039412#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":43.05,"price_display":"43.05","price_state":"stated","total_value":107625.0,"total_display":"107,625.00","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-27","filed_date":"2019-06-28","scope":"insider"},{"id":6291655,"accession":"0001209191-18-034231","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-034231","line_url":"/filing/0001209191-18-034231#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":175000.0,"total_display":"175,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-30","scope":"insider"},{"id":6861872,"accession":"0001209191-18-028892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-028892","line_url":"/filing/0001209191-18-028892#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":27.67,"price_display":"27.67","price_state":"stated","total_value":69175.0,"total_display":"69,175.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-07","filed_date":"2018-05-09","scope":"insider"},{"id":6603576,"accession":"0001209191-18-013130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-013130","line_url":"/filing/0001209191-18-013130#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":538.0,"shares_display":"538","price_per_share":29.6,"price_display":"29.60","price_state":"stated","total_value":15924.8,"total_display":"15,924.80","shares_owned_after":3038.0,"shares_owned_after_display":"3,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-21","filed_date":"2018-02-23","scope":"insider"},{"id":6580220,"accession":"0001209191-18-005242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-005242","line_url":"/filing/0001209191-18-005242#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.5,"price_display":"32.50","price_state":"stated","total_value":325000.0,"total_display":"325,000.00","shares_owned_after":3576.0,"shares_owned_after_display":"3,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-22","filed_date":"2018-01-24","scope":"insider"},{"id":5286514,"accession":"0001209191-17-060706","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-060706","line_url":"/filing/0001209191-17-060706#line-5","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8938.0,"shares_display":"8,938","price_per_share":26.28,"price_display":"26.28","price_state":"stated","total_value":234890.64,"total_display":"234,890.64","shares_owned_after":3576.0,"shares_owned_after_display":"3,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-10","filed_date":"2017-11-14","scope":"insider"},{"id":5286509,"accession":"0001209191-17-060706","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-17-060706","line_url":"/filing/0001209191-17-060706#line-3","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13083.0,"shares_display":"13,083","price_per_share":26.26,"price_display":"26.26","price_state":"stated","total_value":343559.58,"total_display":"343,559.58","shares_owned_after":12093.0,"shares_owned_after_display":"12,093","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-09","filed_date":"2017-11-14","scope":"insider"},{"id":5286506,"accession":"0001209191-17-060706","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-060706","line_url":"/filing/0001209191-17-060706#line-2","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8517.0,"shares_display":"8,517","price_per_share":27.37,"price_display":"27.37","price_state":"stated","total_value":233110.29,"total_display":"233,110.29","shares_owned_after":3576.0,"shares_owned_after_display":"3,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-11-09","filed_date":"2017-11-14","scope":"insider"},{"id":4265996,"accession":"0001209191-17-031570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-031570","line_url":"/filing/0001209191-17-031570#line-1","is_derivative":false,"issuer_cik":"0001689813","issuer_name":"Biohaven Pharmaceutical Holding Co Ltd.","issuer_ticker":"BHVN","issuer_name_source":null,"issuer_url":"/issuer/0001689813","owner_cik":"0001704255","owner_name":"Engelhart James","owner_url":"/insider/0001704255","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":42500.0,"total_display":"42,500.00","shares_owned_after":3576.0,"shares_owned_after_display":"3,576","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-11","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":19,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":19},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001689813","name":"Biohaven Pharmaceutical Holding Co Ltd.","url":"/issuer/0001689813","role":"Officer (Chief Financial Officer)","n_filings":9,"first_seen":"2017-05-11","last_seen":"2021-12-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001704255","retrieved_at":"2026-08-21T19:01:22+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}